Huntington's disease (HD) is an inherited neurodegenerative disorder caused by polyglutamine expansion mutations in the huntingtin protein. Despite its ubiquitous distribution, expression of mutant huntingtin (mHtt) is particularly detrimental to medium spiny neurons within the striatum. Mitochondrial dysfunction has been associated with HD pathogenesis. Here we review the current evidence for mHtt-induced abnormalities in mitochondrial dynamics and quality control, with a particular focus on brain and neuronal data pertaining to striatal vulnerability. We address mHtt effects on mitochondrial biogenesis, protein import, complex assembly, fission and fusion, mitochondrial transport, and on the degradation of damaged mitochondria via autophagy (mitophagy). For an integrated perspective on potentially converging pathogenic mechanisms, we also address impaired autophagosomal transport and abnormal mHtt proteostasis in HD.
Introduction
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease characterized by motor dysfunction, cognitive decline and psychiatric disturbances (Ross and Tabrizi, 2011) . HD is caused by CAG trinucleotide repeat expansion mutations that encode abnormally large polyglutamine (polyQ) stretches at the N-terminal of the huntingtin (Htt) protein (HDCRG, 1993) . Mutations between 36 and 40 polyQ have incomplete penetrance, whereas mutations beyond 41 polyQ are fully penetrant (Walker, 2007) . Individuals express mutant Htt (mHtt) Neurobiology of Disease 90 (2016) [51] [52] [53] [54] [55] [56] [57] Abbreviations: Ambra1, activating molecule in Beclin1-regulated autophagy 1; Atg, autophagy-related protein; BDNF, brain-derived neurotrophic factor; BNIP3, BCL2/adenovirus E1B 19 kDa interacting protein 3; CREB, cAMP response element-binding; DIC, dynein intermediate chain; Drp1, dynamin-related protein 1; FEZ1, fasciculation and elongation protein zeta-1; Fis1, mitochondrial fission 1 protein; GABARAPL1, GABA(A) receptor-associated protein like 1; HAP1, huntingtin-associated protein 1; HDAC, Histone deacetylase; HD, Huntington's disease; Htt, huntingtin; iPS cells, induced pluripotent stem cells; Mff, mitochondrial fission factor; Mfn, mitofusin; mHtt, mutant huntingtin; MiD, mitochondrial dynamics protein; Miro, mitochondrial Rho GTPase; mtDNA/nDNA, mitochondrial/nuclear DNA ratio; MSNs, medium spiny neurons; NIX (BNIP3L), BNIP3-like; NMDAR, NMDA receptor; NRF, nuclear respiratory factor; OPA1, optic atrophy 1; PolyQ, polyglutamine; PPAR, peroxisome proliferator-activated receptor; PGC-1α, PPAR γ coactivator 1α; PINK1, PTEN-induced putative kinase 1; RanBP2, Ran-binding protein 2; Rhes, Ras homolog enriched in striatum; TAF4, TBP (TATA box binding protein)-associated factor 4; TIM, translocase of the inner membrane; TOM, translocase of the outer membrane; TRAK, trafficking kinesin protein; TrkB, tyrosine receptor kinase B.
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